Health TrialsbyHealthPanel

Tailored Exercise to Reduce Aromatase Inhibitor Associated Musculoskeletal Symptoms

ConditionPatients With Early Breast Cancer Who Initiating Adjuvant Aromatase Inhibitor
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMahidol University

About this trial

A randomized controlled study evaluating effect of tailored exercise compared to routine practice as a preventive measure of aromatase inhibitor associated musculoskeletal related symptoms in early breast cancer patients

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

breast cancer patients with starting adjuvant aromatase inhibitor within 4 weeks

able to read and write

Disqualifiers

chronic arthritis

history of heart failure or acute coronary syndrome within 6 months

individuals who exercises regularly more than 150 minutes/week

Trial design

Design model

Parallel

Treatments tested in this trial

  • tailored exercise

    Behavioral

    tailored suitable exercise to individuals recommended for the aim of aerobic exercise at 150 minutes per week and strengthening exercise twice a week

Treatment groups

206 Participants
are divided into 2 treatment groups
Group A: controlNo intervention 0 interventions
Group B: tailored exerciseActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Aromatase inhibitor associated musculoskeletal symptoms (AIMSS)

occurrence of AIMSS

Time frame
12 months

Secondary outcomes

1

worsening pain

reduce numerical scale of pain more than 2 points

Time frame
12 months
2

body weight

body weight change

Time frame
12 months
3

quality of life FACT-ES

FACT-ES score

Time frame
12 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Mahidol University

Lead sponsor

Siriraj Hospital

Sponsor institution

Source ClinicalTrials.gov
Apply now